GPW

1-(beta-D-glucopyranosyl)-5-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione

Created:	2011-08-10
Last modified:	2020-07-17

Find Related PDB Entry
1 entries where GPW is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	36
Chiral Atom Count	5
Bond Count	37
Aromatic Bond Count	0

2D diagram of GPW

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	1-(beta-D-glucopyranosyl)-5-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione
Synonyms	1-(beta-D-glucosyl)-5-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione; 1-(D-glucosyl)-5-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione; 1-(glucosyl)-5-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione
Systematic Name (OpenEye OEToolkits)	1-[(2R,3R,4S,5S,6R)-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dione
Formula	C₁₁ H₁₃ F₃ N₂ O₇
Molecular Weight	342.225
Type	D-SACCHARIDE

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	FC(F)(F)C1=CN(C(=O)NC1=O)C2OC(C(O)C(O)C2O)CO
SMILES	CACTVS	3.370	OC[CH]1O[CH]([CH](O)[CH](O)[CH]1O)N2C=C(C(=O)NC2=O)C(F)(F)F
SMILES	OpenEye OEToolkits	1.7.2	C1=C(C(=O)NC(=O)N1C2C(C(C(C(O2)CO)O)O)O)C(F)(F)F
Canonical SMILES	CACTVS	3.370	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)N2C=C(C(=O)NC2=O)C(F)(F)F
Canonical SMILES	OpenEye OEToolkits	1.7.2	C1=C(C(=O)NC(=O)N1[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)C(F)(F)F
InChI	InChI	1.03	InChI=1S/C11H13F3N2O7/c12-11(13,14)3-1-16(10(22)15-8(3)21)9-7(20)6(19)5(18)4(2-17)23-9/h1,4-7,9,17-20H,2H2,(H,15,21,22)/t4-,5-,6+,7-,9-/m1/s1
InChIKey	InChI	1.03	NADUQTKHANBUDE-XSEHCYKFSA-N

Related Resource References

Resource Name	Reference
PubChem	56603816

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.